Paclitaxel-Based Chemotherapy for Advanced Pancreatic Cancer after Gemcitabine-Based Therapy Failure: A Case Series of 5 Patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Paclitaxel-Based Chemotherapy for Advanced Pancreatic Cancer after Gemcitabine-Based Therapy Failure: A Case Series of 5 Patients

Published:2011 Issue:3 Volume:4 Page:534-541
ISSN:1662-6575
Container-title:Case Reports in Oncology
language:en
Short-container-title:Case Rep Oncol

Author:

Igarashi Hisato,Ito Tetsuhide,Hisano Terumasa,Fujimori Nao,Niina Yusuke,Yasuda Mikihiko,Kaku Toyoma,Matsuo Susumu,Oono Takamasa,Yoshinaga Masahiro,Sakai Hiroyuki,Takayanagi Ryoichi

Publisher

S. Karger AG

Subject

Oncology

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. NRF2 Suppression Enhances the Susceptibility of Pancreatic Cancer Cells, Miapaca-2 to Paclitaxel;Molecular Biotechnology;2023-09-23

2. Recent Developments and Anticancer Therapeutics of Paclitaxel: An Update;Current Pharmaceutical Design;2022-11

3. Potential of hybrid iron oxide–gold nanoparticles as thermal triggers for pancreatic cancer therapy;RSC Advances;2016

4. A study on the effectiveness of additional chemotherapy in patients with advanced pancreatic cancer that have become resistant to the treatment of both S-1 and gemcitabine;Suizo;2013

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP